Latest News

Researchers from Yale Cancer Center participated in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30 to June 3, where they presented the latest research advancements from Yale Cancer Center and Smilow Cancer Hospital.

The Rimm Lab at Yale Pathology, under the direction of David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and professor of medicine (medical oncology), marks 30 years of research, innovation, and training.

Several Department of Pathology faculty members were among more than 100 Yale physicians recognized as top doctors in Connecticut by Connecticut Magazine in its annual Top Doctors issue.

Over 40 Yale Cancer Center researchers will share advances for new therapies at the 2025 ASCO Annual Meeting with research areas covering breast, lung, prostate, head and neck, early onset, and metastatic cancers.

In honor of National Cancer Research Month, Dr. Jeffrey Townsend shares why his research is focused on cancer.

Answers to questions about the causes, warning signs, symptoms and treatments for cancers of the mouth, throat, tongue, and all Head and Neck cancers

Excerpts from a recent conversation on Yale Cancer Answers on Connecticut Public Radio between Peter Glazer, MD, PhD and Eric Winer, MD, the director of the Yale Cancer Center and president and physician-in-chief of the Smilow Cancer Hospital in New Haven.

A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024

Cancers of the head and neck are relatively rare, accounting for less than 4% of cases in the United States, but they are extremely complicated to treat because they attack essential daily functions. A Smilow specialty team coordinates treatment from start to finish.